Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02921919
Title Open-Label Extension and Safety Study of Talazoparib
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Medivation, Inc.
Indications
Therapies
Age Groups: child | senior | adult
Covered Countries USA | POL | HUN | GBR | FRA | DEU | CAN


No variant requirements are available.